$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine
The Trump administration announced a grant to AstraZeneca, which has licensed a potential vaccine that is in trials by Oxford University.
Full Article
$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine
NYTimes.com
0 shares
1 views
You might like
Related news coverage
GSK to produce 1 bln doses of coronavirus vaccine booster in 2021
Reuters India
GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use..
-
GSK to produce 1 billion doses of coronavirus vaccine booster in 2021
Reuters India
-
UK's COVID-19 study aims to vaccinate more than 10,000
SeattlePI.com
-
Moderna's vaccine results added more than $5 billion to the 'big 4' airlines' market values
Business Insider
-
Moderna Prepares to Manufacture a Billion Doses of Coronavirus Vaccine
Motley Fool